Weight-loss jabs may have wider health benefits, study suggests
The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...
Medscape6d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
EXCLUSIVE: Coya Therapeutics Expands Its Pipeline With Combo Therapy For Inflammatory Diseases
Coya Therapeutics, Inc. (NASDAQ:COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for ...
Coya Therapeutics expands investigational pipeline, advancement of COYA 303
Coya Therapeutics (COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for the treatment of inflammatory ...
조선일보8d
Hanmi Pharmaceutical develops obesity drugs to reduce fat and prevent muscle loss
Hanmi Pharmaceutical develops obesity drugs to increase muscle while reducing fat Hanmi Pharmaceutical pioneers innovative ...
pna6d
Study unveils key enzyme in blood sugar control
Israeli and American researchers uncovered the role of a specific enzyme in managing blood sugar levels in a study that opens up new therapeutic possibilities for people with type 2 diabetes. Type 2 ...
AlphaGalileo7d
Study Uncovers Key Role of Enzyme G6PC2 in Controlling Blood Sugar by Regulating Glucagon Secretion
New study shows that the gene G6PC2 plays an important role in regulating glucagon, a hormone that raises blood sugar levels.
Nature14y
Leptin therapy for type 1 diabetes gains traction
Additionally, it will be important to carry out longer-term studies of leptin, alone or in combination with insulin, in a variety of models to determine the utility of suppressing glucagon ...